Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 1006 AL 1020

Systematic review and network meta-analysis of retinal imaging biomarkers in neurodegenerative diseases: Correlation with brain changes

Nikparast F, Ganji Z, Zare H, Akbari-Sharak N.

Photodiagnosis Photodyn Ther. 2025 Aug;54:104632. doi: 10.1016/j.pdpdt.2025.104632. Epub 2025 May 16.

Tailoring the biomarkers of Alzheimer's disease using a gut microbiome-centric approach: Preclinical, clinical, and regulatory perspectives

Sharma S, Bashir B, Kolekar KA, Acharya A, Gupta M, Jena R, Vishwas S, Kaur J, Gupta G, Kumbhar PS, Patle D, Chaitanya M, Gulati M, Singh SK.

Ageing Res Rev. 2025 Dec;112:102888. doi: 10.1016/j.arr.2025.102888. Epub 2025 Sep 1.

Therapeutic Potential for Cannabidiol on Alzheimer's Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis

Wu S, Rajiah T, Ali AB.

Int J Mol Sci. 2025 Dec 11;26(24):11963. doi: 10.3390/ijms262411963.

Molecular Crossroads: Shared and Divergent Molecular Signatures in Alzheimer's Disease and Dementia with Lewy Bodies

Neupane S, Hortobágyi T.

Int J Mol Sci. 2025 Dec 7;26(24):11811. doi: 10.3390/ijms262411811.

Early detection of Alzheimer's disease progression: comparative evaluation of deep learning models

Shetty J, Shenoy MK, Kolekar SV, Prabhu MM, Kotha RR, Bhardwaj S.

Sci Rep. 2025 Dec 5;15(1):43242. doi: 10.1038/s41598-025-27360-8.

Imaging markers of neuroinflammation in aging and Alzheimer's disease and related dementia: A comprehensive review

Chaudhary S, Chao HH, Agarwal K, Gupta S, Li CR.

Neurosci Biobehav Rev. 2025 Sep;176:106270. doi: 10.1016/j.neubiorev.2025.106270. Epub 2025 Jun 25.

Diabetes affects AD through plasma Aβ40: A Mendelian randomization study

Yang Q, Huang D, Zhang Z, Gao H, Wu J, Zhong H, Guo X, Wang Y, Zhou H, Liu C, Duan X.

Neuroscience. 2025 May 24;575:131-139. doi: 10.1016/j.neuroscience.2025.04.025. Epub 2025 Apr 13.

Alzheimer's disease: assessing the therapeutic potential of anti-Aβ (Beta-Amyloid) treatments

Almutairi JA.

Cell Mol Biol (Noisy-le-grand). 2025 Feb 2;71(1):111-117. doi: 10.14715/cmb/2025.70.1.12.

The Interplay Between Exosomes and Gut Microbiota in Neuroinflammation: A New Frontier in Alzheimer's Disease

Uceda S, Reiriz M, Echeverry-Alzate V, Beltrán-Velasco AI.

Int J Mol Sci. 2025 Jun 18;26(12):5828. doi: 10.3390/ijms26125828.

Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer's Disease and Frontotemporal Dementia

Petracci I, Bellini S, Goljanek-Whysall K, Quinlan LR, Fiszer A, Cakmak A, Njume CM, Borroni B, Ghidoni R.

Int J Mol Sci. 2025 Apr 5;26(7):3399. doi: 10.3390/ijms26073399.

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort

Bali D, Salvadó G, Beach TG, Serrano GE, Atri A, Reiman EM, Jeromin A, Hansson O, Janelidze S.

Acta Neuropathol Commun. 2025 Jun 30;13(1):144. doi: 10.1186/s40478-025-02064-2.

Beyond binary classification: Comparing three region-based multi-phase Aβ staging systems

Cui L, Zhang Z, Huang CC, Yuan CY, Tu YY, Wang M, Guan YH, Li YH, Xie F, Guo QH.

Alzheimers Dement. 2025 May;21(5):e70253. doi: 10.1002/alz.70253.

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Wang S, Xi J, Zhang M, Wang J.

Int J Biol Macromol. 2025 Mar;294:139394. doi: 10.1016/j.ijbiomac.2024.139394. Epub 2025 Jan 3.

Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome

Huber H, Arranz J, Arslan B, Leuzy A, Kittel O, di Molfetta G, Benejam B, Videla L, Barroeta I, Soriano LDH, Maure-Blesa L, Rodríguez-Baz Í, Arriola Infante JE, Illán-Gala I, Bejanin A, Montoliu-Gaya L, Lleó A, Carmona-Iragui M, Alcolea D, Blennow K, Zetterberg H, Fortea J, Ashton NJ.

Nat Commun. 2025 Nov 10;16(1):9900. doi: 10.1038/s41467-025-65882-x.

Lipofuscin accumulation in aging and neurodegeneration: a potential "timebomb" overlooked in Alzheimer's disease

Dougnon G, Matsui H.

Transl Neurodegener. 2025 Dec 12;14(1):67. doi: 10.1186/s40035-025-00529-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias